-
1. Calderon, R. M.; Cubeddu, L. X.; Goldberg, R. B.; Schiff, E. R. Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: A therapeutic dilemma. Mayo Clinic Proc. 2010, 85(4), 349–56.
-
2. Liao, J. K.; Laufs, U. Pleiotropic effects of statins. Annu. Rev. Pharmacol. Toxicol. 2005, 45, 89–118.
-
3. Schachter, M. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam. Clin. Pharmacol. 2005, 19(1), 117–25.
-
4. Patel, M.; Kothari, C. Critical review of statins: a bio-analytical perspective for therapeutic drug monitoring. TrAC Trends Anal. Chem. 2017, 86, 206–21.
-
5. Abdallah, O. M. RP-HPLC determination of three anti-hyperlipidemic drugs in spiked human plasma and in dosage forms. EJournal Chem. 2011, 8(2), 753–61.
-
6. Delhi Raj, N.; Kumaravel, S.; Murugan, R.; Sriman Narayanan, S.; Vijayalakshmi, R. Reverse phase HPLC method for the determination of Pravastatin in tablet dosage forms. Int. J. Res. Pharm. Sci. 2010, 1, 187–9.
-
7. Płotka, J.; Tobiszewski, M.; Sulej, A. M.; Kupska, M.; Górecki, T.; Namieśnik, J. Green chromatography. J. Chromatogr. A 2013, 1307, 1–20.
-
8. Yang, Y.; Strickland, Z.; Kapalavavi, B.; Marple, R.; Gamsky, C. Industrial application of green chromatography–I. Separation and analysis of niacinamide in skincare creams using pure water as the mobile phase. Talanta 2011, 84(1), 169–74.
-
9. Fi, L.; Coutinho, M.; Nazario, C. E. D.; Monteiro, A. M.; Lanças, F. M. Novel devices for solvent delivery and temperature programming designed for capillary liquid chromatography. J. Sep. Sci. 2014, 37(15), 1903–10.
-
10. Assassi, A. L.; Roy, C. -E.; Perovitch, P.; Auzerie, J.; Hamon, T.; Gaudin, K. Green analytical method development for statin analysis. J. Chromatogr. A. 2015, 1380, 104–11.